Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion

NCT03313752 is registered in ClinicalTrials.gov with Giaccari Andrea as lead sponsor.

NCT NCT03313752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion
Lead sponsor
Giaccari Andrea
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2017
Completion date
October 6, 2022
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stable coronary artery disease, type2 diabetes mellitus